Daniel James George, MD | Authors


How Cabozantinib is Being Used in Practice for Patients With RCC

April 28, 2017

Daniel James George, MD, professor of Medicine, professor in Surgery, Duke University School of Medicine, discusses how cabozantinib (Cabometyx) is currently being used in practice for patients with renal cell carcinoma (RCC).